Dongguan east sunshine industrial development co., LTD., 50 kinds of research and development of new drugs

Source: dongguan time nets

The 2016-04-26 09:45:15

Reporter: Shen Hanyan

Dongguan east sunshine industrial development co., LTD., won the "guangdong province May Day labor diploma"

Founded institute for research and development more than 50 kinds of new drugs

[editor's note]

In the coming May Day, to build respect labor model, concerned about the labor model, good social atmosphere of learning model, city of dongguan times joint acftu launched "Chinese dream, labor - prize above switching from dongguan new style" series, near dongguan city was named the "2016 national workers pioneer, the national May 1 labor medal, the worker pioneer of guangdong province, the May Day labor diploma (MEDALS)" a model such as advanced collectives and individuals that share with you the most beautiful laborer the story behind the heavy medal, please note!

Located in changan town, dongguan city east sunshine industrial development co., LTD., is a collection research and development, production, sales in the integration of large joint-stock enterprises, with annual sales of more than 20 billion yuan, the company industry mainly concentrated in the east the sun technology, east sun medicine and nanling keeping in good health, etc.

East sun company actively promote institutional innovation, in the form of the general enterprise legal system management, has always been to "a can romped in the army, a training school, a harmonious family" as the goal of organization construction. To share reform in 2009, and has set up a long-term equity and management equity stake, technology project, set up a legal system management, research and development system perfect, the modern enterprise of noticeable realistism is perseverance. This year, the company has obtained "May 1 labor certificate of guangdong province" title of honor.

More than ten years of persistent research and development of new drugs

East sun company original department laboratory of new drug, the competent Yu Tianxi introduction, as early as in 2005, the company established research institute, consists of the sunshine and the east east sun medicine institute, two six. After more than 10 years of development, now has more than 1600 research and development personnel, more than 40 foreign and overseas experts, more than 100, more than 1000 master degree, especially with 30 international chemical structure to create division, forming the unique "tribes of elite dominated, sea turtles, expert guidance, overseas consultant" development pattern.

In addition to the large and efficient research and development team, the east sunshine company institute has 50000 ㎡ standard laboratory, 20 ms instrument, two nuclear magnetic resonance (NMR), 40 sets of more than 400 sets of high performance liquid chromatography (HPLC) and gas chromatography, and XRD diffraction, Raman spectrometer, online crystal particle size analyzer and so on the many kinds of form a complete set of world advanced, complete testing instruments.

At present, the east sunshine company r&d project a total of more than 230, with completely independent intellectual property rights of new drugs in development with a total of 50, is divided into six areas, anti-infection areas (especially the field of liver disease), antitumor, nervous system, metabolic disorders, cardiovascular disease, and immune inflammation. In key projects have hepatitis b infection medicine projects, anti fibrosis, cordyceps sinensis, antitumor projects, such as the United States first imitation drugs and generic drugs.

"Won the national hepatitis b project approval documents of the phase 2, 3, iii, is now ready to doing c project phase 2 clinical trials, the effect is very good." Yu Tianxi said, east sun company is developing anti-tumor project have 12 female nucleus, especially in pancreatic cancer, lung cancer, leukemia with original attainments; Very rare pancreatic cancer project once obtained the national phase 1, 2, 3, approval, are now being human clinical trials.

To enter the market, industrial transformation and upgrading to see results

The reporter understands, east sun company is given priority to with traditional processing industry, more than 10 years ago to transition to the pharmaceutical industry as the core of large health industry; Initial success in 2015, the effect of the transformation and upgrading, oseltamivir phosphate as the core of the generic drug profits in 2015 through 300 million yuan. Give priority to with the winning 22 German insurance company's overseas generics profits in 2015, 50 million yuan; Cordyceps sinensis profits in 2015 through 2015 yuan; Macrocyclic lactones and API 2015 profit of nearly 2015 yuan. The whole pharmaceutical industry in 2015, profits of 1 billion yuan; Is expected in 2016 east sun medicine profit nearly 2 billion yuan. 2015 east sun medicine approved by the state into human clinical medicine and cosmetics more than 60, 2016 is expected to 100.

At present, the "east sunshine", "Hong Kong east sun medicine" has been successfully listed, east sunshine company is "east sun yan", "China east sun medicine", "the United States east sun medicine", "east sunshine" listed companies, financial companies and domestic and foreign life insurance companies are preparing.

At present, the "east" sunshine is the largest domestic foil, electronic light into hydrophilic foil, foil and electrochemical production of the largest in guangdong province listed companies; Is the domestic coal resources exploitation, port and the Yangtze river water transportation and thermal power enterprises; Is the domestic r&d refrigerants, such as fluorine resin, fluorine chemical science and technology personnel is more excellent, experiment equipment is one of the main unit; Is the domestic research and development of components, systems technology such as science and technology personnel is more excellent experimental equipment is one of the main unit.

"East sun medicine" is currently the world's largest production of macrocyclic lactones and through the FDA certification of enterprises; Is the largest domestic oseltamivir phosphate production base; Is the production of insulin biological medicine one of the highest level; Is the most powerful research and development, the overseas registration, production of Europe and the United States and other developed countries generics companies; Is the independent research and development, independent registration, at the same time by the FDA, the European Union, the world health organization (who), the CFDA certification of the first domestic pharmaceutical enterprises in China; Is more overseas experts in domestic enterprises, well-equipped, and the United States FDA standards, the strongest new drug research and development enterprise.